Meet Dr. Yanwu Guo, Senior Research Investigator at ModelMole & founder of ANGENOVO AS. Bridging academia and industry, he leverages AI and computational methods to drive next-gen biotech innovation with an entrepreneurial mindset.
We combine cutting-edge computational chemistry and physics with advanced machine learning algorithms to identify and prioritise novel therapeutic targets. ModelMole unifies the entire drug discovery stack into a single intelligent system.
With a PhD from IBB, PAN in Poland and research roles at the University of Oslo and the Friedrich Miescher Institute, Yanwu connects academic rigor with industry needs. He specialises in leveraging computational approaches and AI to build next-generation biotechnology solutions. Drawing from his journey as the founder of ANGENOVO AS, he brings a entrepreneurial and tech-forward mindset to driving biotech innovation.
Dr. Yanwu Guo offers expertise in bridging academia and industry through AI and computational methods. With a PhD from IBB, PAN and vast research experience, he provides strategic insights for next-generation biotechnology solutions.
Partner with ModelMole to accelerate drug discovery. we leverage advanced AI, machine learning, and computational biology to build next-generation therapeutics. Seeking biotech and pharma partners for collaborative R&D.